Stockreport

More on Taro Pharmaceutical Q4 results [Seeking Alpha]

B. Riley Financial, Inc.  (RILY) 
NASDAQ:AMEX Investor Relations: ir.brileyfin.com/investor-relations
PDF More on Taro Pharmaceutical Q4 resultsTaro Pharmaceutical (TARO-1.4%)reports Q4 revenue decrease of 10.8% Y/Y to $175.22M; despite an increase in overall volumes revenue [Read more]